The Dimerization Domain in DapE Enzymes Is required for Catalysis

PLOS ONE, May 2014

The emergence of antibiotic-resistant bacterial strains underscores the importance of identifying new drug targets and developing new antimicrobial compounds. Lysine and meso-diaminopimelic acid are essential for protein production and bacterial peptidoglycan cell wall remodeling and are synthesized in bacteria by enzymes encoded within dap operon. Therefore dap enzymes may serve as excellent targets for developing a new class of antimicrobial agents. The dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) converts N-succinyl-L,L-diaminopimelic acid to L,L-diaminopimelic acid and succinate. The enzyme is composed of catalytic and dimerization domains, and belongs to the M20 peptidase family. To understand the specific role of each domain of the enzyme we engineered dimerization domain deletion mutants of DapEs from Haemophilus influenzae and Vibrio cholerae, and characterized these proteins structurally and biochemically. No activity was observed for all deletion mutants. Structural comparisons of wild-type, inactive monomeric DapE enzymes with other M20 peptidases suggest that the dimerization domain is essential for DapE enzymatic activity. Structural analysis and molecular dynamics simulations indicate that removal of the dimerization domain increased the flexibility of a conserved active site loop that may provide critical interactions with the substrate.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093593&type=printable

The Dimerization Domain in DapE Enzymes Is required for Catalysis

et al. (2014) The Dimerization Domain in DapE Enzymes Is required for Catalysis. PLoS ONE 9(5): e93593. doi:10.1371/journal.pone.0093593 The Dimerization Domain in DapE Enzymes Is required for Catalysis Boguslaw Nocek 0 Anna Starus 0 Magdalena Makowska-Grzyska 0 Blanca Gutierrez 0 Stephen Sanchez 0 Robert Jedrzejczak 0 Jamey C. Mack 0 Kenneth W. Olsen 0 Andrzej Joachimiak 0 Richard C. Holz 0 Andre O. Hudson, Rochester Institute of Technology, United States of America 0 1 Center for Structural Genomics of Infectious Diseases, Computation Institute, University of Chicago , Chicago , Illinois, United States of America, 2 The Department of Chemistry and Biochemistry, Loyola University-Chicago , Chicago , Illinois, United States of America, 3 The Midwest Center for Structural Genomics, Bioscience Division, Argonne National Laboratory, Lemont, Illinois, United States of America, 4 Department of Chemistry, Marquette University , Milwaukee, Wisconsin , United States of America The emergence of antibiotic-resistant bacterial strains underscores the importance of identifying new drug targets and developing new antimicrobial compounds. Lysine and meso-diaminopimelic acid are essential for protein production and bacterial peptidoglycan cell wall remodeling and are synthesized in bacteria by enzymes encoded within dap operon. Therefore dap enzymes may serve as excellent targets for developing a new class of antimicrobial agents. The dapEencoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) converts N-succinyl-L,L-diaminopimelic acid to L,Ldiaminopimelic acid and succinate. The enzyme is composed of catalytic and dimerization domains, and belongs to the M20 peptidase family. To understand the specific role of each domain of the enzyme we engineered dimerization domain deletion mutants of DapEs from Haemophilus influenzae and Vibrio cholerae, and characterized these proteins structurally and biochemically. No activity was observed for all deletion mutants. Structural comparisons of wild-type, inactive monomeric DapE enzymes with other M20 peptidases suggest that the dimerization domain is essential for DapE enzymatic activity. Structural analysis and molecular dynamics simulations indicate that removal of the dimerization domain increased the flexibility of a conserved active site loop that may provide critical interactions with the substrate. - Funding: This research has been funded in part by grants from the National Institutes of Health R15 AI085559-01A1 (RCH), GM094585 (AJ), Contract HHSN272200700058C and HHSN272201200026C (AJ), from the National Science Foundation CHE-1004430 (KWO), and by the U.S. Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. Emerging antibiotic resistance has been recognized as a worldwide health issue since the introduction of penicillin more than 80 years ago [1,2]. Most importantly, the rapid emergence of resistant bacteria makes todays antibiotics more and more ineffective, consequently increasing the need for a novel class of antibacterial agents [3]. Currently available antibiotics target only a limited number of microbial pathways and employ two major strategies: (i) inhibition of cell wall remodeling and (ii) inhibition of protein synthesis. As a result, only two new classes of antibacterial drugs have reached the market since 1962. The Center for Disease Control and Prevention (CDC) recently reported the emergence of several strains of Staphylococcus aureus that are resistant to even the most powerful antibiotic of last resort, vancomycin. These cases emphasize the fact that no drug can prevent a simple staph infection from becoming deadly [4]. According to the Infectious Diseases Society of America, a minimum of ten new systemic antibacterial drugs need to enter the market by the year 2020 in order to maintain proper control of infectious diseases. Therefore, development of new classes of inhibitors that target essential metabolic pathways and unique enzymes is critical in order to maintain control of infectious diseases [5,6]. The lysine biosynthetic pathway offers several enzymes that could serve as potential drug targets [7,8]. Two products of this pathway, lysine and meso-diaminopimelate (mDAP), are essential for protein and peptidoglycan cell wall synthesis in Gram-negative and most Gram-positive bacteria. Many bacteria, plants and algae synthesize lysine and meso-diaminopimelic acid (mDAP) from succinic acid [9,10,11]. In contrast, lysine is not synthesized in humans but it is an essential amino acid, therefore it must be ingested. It has been shown that deletion of the dapE gene in the mDAP/lysine biosynthetic pathway that encodes the N-succinylL,L-diaminopimelic acid desuccinylase (DapE) is lethal in Helicobacter pylori and Mycobacterium smegmatis [12,13]. DapE hydrolyzes N-succinyl-L,L-diaminopimelic acid to L,L-diaminopimelic acid and succinate, is part of a biosynthetic pathway that is the major source of lysine in bacteria, and is essential for cell growth and proliferation. Since there are no similar biosynthetic pathways in mammals, inhibitors that target DapEs are hypothesized to exhibit selective toxicity against bacteria and have little or no effect on humans [9,14]. DapE coding genes have been identified in all pathogenic Gram-negative bacteria, and the enzyme has been purified and characterized from several sources [8]. Of particular interest are DapEs from the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacter species), which account for more than 60% of the antibiotic resistant hospital acquired infections in the United States (1318). Alignment of the DapE gene from Haemophilus influenzae (HiDapE) with the gene sequences of DapEs from ESKAPE pathogens reveals at least 49% identity [15]. All the DapE enzymes characterized to date belong to the M20 family of dinuclear Zn(II)-dependent metalloproteases. Structural studies of M20 metalloproteases showed that these enzymes exist as dimers comprised of catalytic and dimerization domains or monomers having a single catalytic domain (16). Structural studies on HiDapE revealed that the enzyme belongs to the former group composed of a larger thioredoxin-like 3-layer (aba) sandwich domain that carries out catalysis and a smaller ferrodoxin-like domain providing the dimer interface [16]. The core of the catalytic domain consists of an eight-stranded twisted b-sheet that is sandwiched between seven a-helices and houses the active site. The active site is constituted by residues from five loops, contains two zinc ions, and is exposed to the solvent. The architecture of the active site of HiDapE and the core of the catalytic domain are strikingly similar to the aminopeptidase from Aeromonas proteolytica (AAP) and the carboxypeptidase from Pseudomonas sp strain-RS-16 (CPG2) [17,18], even though they catalyze markedly different hydrolytic reactions. One explanation for this similarity is the highly flexible design of their active sites, which are constructed by five loops. This design preserves the dinuclear catalytic core and at the same time allows for evolution of specificity for new substrates without the need for major modifications to the overall structure. The flexibility of the active site is especially relevant from the perspective of understanding substrate recognition and binding, which is directly related to inhibitor design. In order to examine the role of the catalytic domain of DapE enzymes and the role of the active site loops, we have engineered the HiDapE and the DapE from Vibrio cholerae (VcDapE) by deleting their dimerization domains. This truncation leads to protein constructs that have only the catalytic domain, are monomeric in solution, and closely resemble AAP. Kinetic characterization of the truncated DapEs (VcDapET and HiDapET) shows that the catalytic domain alone is completely inactive. X-ray crystallographic data and molecular dynamic simulations along with site-directed mutagenesis studies provide insight into the role of the dimerization domain and underlying importance of the active site loops in catalysis. Materials and Methods Gene cloning and protein expression The coding genes of full-length VcDapE and HiDapE were cloned into vector pMCSG7 and amplified by PCR from V. cholerae O1 biovar El Tor str. N16961 (ATCC) and from H. influenzae strain (ATCC), respectively, with KOD DNA polymerase using conditions and reagents according to the standard protocol described previously [19]. The truncated version of HiDapET (residues 181294 deleted) and VcDapET (residues 181295 deleted) were designed based on the full-length HiDapE structure and were cloned using the same procedure. These deletion proteins were reengineered in such a way that the C-terminal domain was truncated at the connector region between the dimerization and the catalytic domains and replaced with a GG linker. The deletion of the region coding for the dimerization domain was achieved via PCR of pMCSG7-VcDapE and pMCSG7-HiDapE according to the previously described protocol [20]. The following primers were used: VcDapET 181295; 59TGGCGGTGGCTTCCTGACCGATACGGGCGA39 and 59GGAAGCCACCGCCACGACGGCCATTTTTCACC39, HiDapET 181294; 59CGGCGG TGGCTTTTTAACAAAACCAGGTAAATTATTAGATTCGATAACC39 and 59AAAAAGCCACC GCCGCGGCGACCATTTTTGAC39. This process generated expression clones of fusion proteins that have an N-terminal His6-tag, a TEV protease recognition site (ENLYFQQS), followed by the DapE catalytic domain. All proteins were expressed in an E. coli BL21(DE3)-derivative that harbors the pMAGIC plasmid encoding one rare E. coli Arg tRNA (covering codons AGG/AGA). The transformed BL21(DE3) cells were grown at 37uC in Luria-Bertani medium and protein expression was induced with 1 mM isopropyl-b-d-thiogalactoside (IPTG). The cells were then incubated and shaken vigorously at 18uC overnight. The harvested cells were re-suspended in lysis buffer (500 mM NaCl, 5% (v/v) glycerol, 50 mM HEPES, pH 8.0, 10 mM imidazole, 10 mM 2-mercaptoethanol) and stored at 280uC. Purification of VcDapE, VcDapET and HiDapET The VcDapE, VcDapET and HiDapET proteins were purified according to the standard protocol for Ni-NTA affinity chromatography, as described previously [19]. The His6-tag was removed by treating each enzyme with His6-tagged TEV protease for 16 h at 4uC in 50 mM HEPES, pH 8.0. Cleaved protein was separated from TEV using Ni-NTA affinity chromatography. After Ni-NTA column chromatography, VcDapET and HiDapET were further purified by size-exclusion chromatography on a HiLoad 16/600 Superdex 200 Prep Grade (GE Healthcare) using standard crystallization buffer (250 mM NaCl, 20 mM HEPES pH 8.0, and 1 mM TCEP) and concentrated to 25 mg/ml. The full-length VcDapE protein was purified according to the same procedure however the size-exclusion chromatography step revealed formation of soluble aggregates. Therefore, the buffer conditions were altered such that the salt concentration was increased to 800 mM NaCl and glycerol (10%) was added, allowing for purification of small quantities of soluble protein. Kinetic characterization of VcDapE, VcDapET, and HiDapET Recombinant WT-VcDapE, VcDapET, and HiDapET were characterized biochemically by monitoring amide bond cleavage of L,L-SDAP at 225 nm (e = 698 M21 cm21). The assay was performed in triplicate in 50 mM phosphate buffer, pH 7.5, in the presence of two equivalents of Zn(II). Enzyme activities were expressed as units/mg where one unit is defined as the amount of enzyme that releases 1 mmol of L,L-SDAP at 25uC in 1 min. Km and kcat values were obtained by fitting initial rates data to the Michaelis-Menten equation using Origin software [21,22,23]. Catalytic activities were determined with an error of 610%. Protein crystallization The sitting-drop vapor-diffusion method was used to obtain crystals of VcDapET and HiDapET at 16uC using a Mosquito liquid handling robot with 96 well plates. Crystals of both the apoand dinuclear Zn(II)-loaded forms of VcDapET were obtained using 400 nl of a precipitant solution (20% (v/v) 1,4-butanediol, 0.1 M sodium acetate pH 4.5) and 400 nl a 19 mg/ml solution of VcDapET in crystallization buffer, within 14 days. In order to grow the crystals of dinuclear Zn(II)-loaded forms of VcDapET, a 1 mM ZnCl2 solution was added to the protein solution. Crystals of HiDapET were obtained using 400 nl of a precipitant solution (0.2 M ammonium acetate, 0.1 M BIS-TRIS pH 5.5, 25% (w/v) polyethylene glycol 3350) and 400 nl of a 15 mg/ml solution of HiDapET within two weeks. The asymmetric unit contains two monomeric molecules of the HiDapET. For cryo-protection, all crystals were transferred to the mother liquid containing a 25% mixture of glycerol and ethylene glycol. Data collection and structure determination Prior to data collection, the X-ray florescence spectrum was recorded for VcDapET, HiDapET and apo-VcDapET crystals, which identified the presence of Zn ions in the protein crystals of VcDapET and HiDapET. Data collection was carried out on the 19-ID beam line of the Structural Biology Center at the Advanced Photon Source according to procedures described previously [16]. Data were collected at a wavelength of 0.98 A from the single crystals and were processed using HKL3000. Crystallographic parameters are summarized in Table 1. Initially, data for VcDapET and HiDapET were processed, scaled and the structures refined in the space group P3212. Even though these models refined with low R-factors (Rcryst/Rfree = ,16/18%), spurious density features were observed in the electron density maps. Reexamination of these data suggested a twinning test be performed using Xtriage in Phenix [24], which indicated twinning. The twinning operator is parallel to the two-fold axis making the space group pseudo P3212. Therefore, data were rescaled in the space group P32. The structures of VcDapET and HiDapET were determined by molecular replacement using the catalytic domain of HiDapE (PDB ID 3IC1) as a search model [16]. Molecular replacement searches were completed using MOLREP of the CCP4 suite [25,26]. The initial models were rebuilt manually and refined using programs REFMAC 5.5 [27] and Phenix [24]. The final models were refined against all reflections except for 5% randomly selected reflections, which were used for monitoring Rfree. The final rounds of refinement were carried out using TLS refinement with 5 TLS groups. The final refinement statistics for all structures are presented in Table 1. Analysis and validation of the structures were performed with the aid of MOLPROBITY and COOT validation tools. Figures were prepared using Pymol. Protein Data Bank accession code The atomic coordinates and structure factor file for the structure of the catalytic domain of apo-VcDapET, ZnZnVcDapET and ZnZn-HiDapET have been deposited in the RCSB Protein Bank with accession code 4ONW, 4OP4 and 4H2K, respectively. Determination of Molecular Weight of VcDapE, VcDapET and HiDapET The molecular weight (MW) of the HiDapE, HiDapET and VcDapET proteins in solution were determined using sizeexclusion chromatography (SEC) on a HiLoad 16/600 Superdex 200 Prep Grade column (GE Healthcare) in the crystallization buffer at 5 mg/ml concentrations. The column was calibrated with aprotinin (6.5 kDa), ribonuclease A (13.7 kDa), carbonic anhydrase (29 kDa) ovalbumin (43 kDa), conalbumin (75 kDa), aldolase (158 kDa), ferritin (440 kDa), and thyroglobulin (669 kDa) as standards. A calibration curve of Kav vs. log MW was prepared using the equation Kav = Ve2Vo/Vt2Vo, where Ve = elution volume for the protein, Vo = column void volume, and Vt = total bed volume (Supplementary Materials Figure S1A in File S1). Dynamic light scattering (DLS) assessments DLS analyses were performed using the DynaPro-801 molecular sizing instrument (Protein Solutions) at 21uC. Aliquots of protein samples collected from the SEC column were concentrated to a final concentration of 2.0 mg/ml in the crystallization buffer. The solutions were filtered with Ultrafree-MC microcentrifuge filters (0.22 mm, Millipore) and centrifuged at 20,000 g for 10 min at 4uC and before measurements were taken. Hydrodynamic radii (RH), degree of sample polydispersity and MWs were calculated using the manufacturers software version 5.25.44. Molecular modeling and dynamics simulations The structure of the catalytic domain of VcDapET is well ordered and excellent electron density is observed for protein main-chain, side-chains, metal, phosphate ions, and water molecules. Using the VMD molecular graphics program [28], the protein model with its hydrogen atoms was created and placed in a water-box containing 7826 TIP3 water molecules [29], 13 sodium, and 2 chloride ions to neutralize the charge and provide counter ions. The charges on the histidine residues were determined by inspection of their local environments. The energy of this initial structure was minimized with 3,000 steps of conjugated gradient minimization using the CHARMM27 force field [30] and the NAMD molecular dynamics (MD) program [31]. The structure was relaxed by gradually heating it from 10 to 310 K in steps of 10 K with 1,000 steps of molecular dynamics at each temperature. Periodic boundary conditions were used. The cutoffs for non-bonding (van der Waals and electrostatic) interactions were 12 A. The switch distance was 10 and 1.0 A using a 14 scaling factor. The time step was 2 fs. These conditions were used for all of the molecular dynamics simulations. After 10,000 steps of pressure and temperature equilibration using a Langevin piston, the system was subjected to 30,000 steps of molecular dynamics. This process constitutes equilibration of the structure. The structures for HiDapET and HiDapE were also equilibrated in the same manner. Since these X-ray structure models had a few loops missing due to the poor electron density maps, the missing regions were modeled using the modeling tools found in Swiss PDB Viewer [32]. The complete VcDapE structure was produced through homology modeling, using HiDapE as a template through the automated mode of the Swiss Model service [33]. The two chains of VcDapE were produced separately from each other, combined using VMD, and equilibrated in the manner previously described. The X-ray structure for AAP (PDB ID 1RTQ) [18] was used as a standard for comparison as AAP and dinuclear Zn(II)-loaded VcDapET and HiDapET are characterized by similar active sites and sequence lengths. For each of these five structures, 5 ns of simulation data were accumulated. The rmsd per residue values were calculated for MD production runs of the four structures using the VMD molecular graphics program [28]. These calculations were used to determine structural changes between each of the five structures. MOLMOL plots [34] were also generated for each structure to give a visual depiction of the structural changes, especially for areas of large movement. For these diagrams 171 equally spaced snapshots over a 5 ns simulation were used for each of the five proteins. Three of the simulations (ZnZn(VcDapET), HiDapET and HiDapE) were run for 10 ns, but there were no significant differences in the flexibilities of these when the second 5 ns simulations were compared with the first 5 ns. Loop V Site Directed Mutagenesis The site-directed mutants T325A, T325S and T325C of WTHiDapE were prepared using the Quick Change Site-Directed Mutagenesis Kit (Stratagene) following the procedure outlined by Stratagene using the following primers, T325A: 59ACAGGTGGCGGCGCGTCAGACGGTC-39, 59GACCGTCTGACGCGCCGCCACCTGT-39, T325S: 59ACAGGTGGCGGCTCGTCAGACGGTC-39, 59 Data collection statistics Number of observed reflections Number of unique reflections Completenessb (%) bond lengths (A) Rmsd from target values Average B factors (A 2) Ramachandran (%)c M.F./A.A. zinc ion/acetate/butanediol/glycerol/ethanediol/ VcDapET-ZnZn a = 49.6 a = 49.9 b = 49.9 a = 61.7 b = 44.7 c = 92.5 b = 92.9u Rrim~Shkl N.N{11=2 SijIi(hkl){Ihklj=Shkl SiIihkl, and Rpim~Shkl 1.N{11=2 Si Ii(hkl){Ihkl =Shkl SiIihkl. bNumbers in parentheses are values for the highest-resolution bin. cAs defined by MOLPROBITY (M.F. the most favored/A.A additionally allowed). doi:10.1371/journal.pone.0093593.t001 aRmerge = ShklSi|Ii(hkl)2Ihklae|/ShklSiIi(hkl), where Ii(hkl) is the ith observation of reflection hkl, and Ihklae is the weighted average intensity for all observations i of reflection hkl. GACCGTCTGACGAGCCGCCACCTGT-39, T325C: 59 GCTGAAACAGGTGGCGGCTGCTCAGACGGTCGTTT TATT-39, 59-AATAAAACGACCGTCTGAGCAGCCGCCACCTGTTTCAGC-39. Polymerase Chain Reaction (PCR) was performed using 70 ng of a dsDNA template. PCR was performed at 95uC for 30 seconds followed by 16 cycles of (95uC for 30 seconds, 55uC for 1 minute, 68uC for 5 minutes) and final extension at 68uC for 6 minutes. Reaction products were transformed into BL21(DE3)/magic E. coli competent cells (Invitrogen) and grown on Luria-Bertani agarose plates containing ampicillin (100 mg mL21) and kanamycin (25 mg mL21). A single colony of each mutant was grown in 5 mL Luria-Bertani medium containing ampicillin (100 mg mL21) and kanamycin (25 mg mL21). Plasmids were isolated using the QIAprep-Spin Miniprep Kit (QIAGEN). The plasmid DNA was sent to the DNA sequencing facility (University of Chicago Cancer Research Center DNA Sequencing Facility, Chicago IL) to confirm the mutations. Glycerol stocks were prepared and stored at 280uC until further needed. Purification of HiDapE T325A, T325C and T325S mutant enzymes and kinetic characterization was conducted as described above. Circular dichroism (CD) spectra were recorded on an Olis DSM-20 CD spectrophotometer at 25uC in 50 mM HEPES, 300 mM NaCl at pH 7.5 (Supplementary Materials Figure S1B in File S1). Kinetic characterization of wild-type and truncated DapE Kinetic data were obtained for recombinant VcDapE, HiDapE, VcDapET, and HiDapET by monitoring amide bond cleavage of L,L-SDAP at 225 nm. The kcat value obtained for WT-VcDapE was 80610 s21, with a corresponding Km value of 1.260.2 mM while the kcat value obtained for HiDapE was 114610 s21, with a Km value of 0.860.1 mM, which is in good agreement with previous studies [23] (Surprisingly, no detectable activity was observed for HiDapET or VcDapET under the standard assay conditions. Structure of the catalytic domain of HiDapET Deletion of the dimerization domain led to a monomeric structure for HiDapET. The monomeric nature of HiDapET in solution was corroborated by size exclusion chromatography (SEC) and dynamic light scattering (DLS). The SEC analysis confirmed a weight (MW) of 28.4 kDa (the theoretical mass of a monomer is 28.9 kDa, while the wild-type dimers theoretical mass is 82.6 kDa) (Supplementary Material Figure S1A in File S1). DLS experiment revealed a monomodal solution containing particles with an average hydrodynamic radius of the 2.52 nm and an estimated average MW of 28.7 kDa (Table 2). The structure of HiDapET was determined and refined at 1.84 A resolution and the final model shows two independent monomers in the asymmetric unit. The structure of the catalytic domain is virtually identical to the catalytic domain of full-length HiDapE (PDB ID 3IC1) (Figure 1A, B, & C) [16]. Both structures overlay closely with rmsd for Ca atoms of 0.65 A over 254 residues. Two zinc atoms were found in the active site and reside in the same position as in dimeric structure of WT-HiDapE separated by 3.40 A. Superimposition of the active site regions shows nearly identical conformations of main chain and side chains with rmsd as low as 0.15 A for the metal ions and side chains of residues involved in their coordination (Figure 1C). Therefore the structure of the catalytic core of the enzyme is extremely well preserved in the truncated enzymes. Larger differences within the active site area are observed in two regions containing solvent exposed loops. Region I (residues 176187) has been engineered to replace what was originally the connector/hinge region formed by two loops linking the catalytic domain with the dimerizaton domain (Figure 1C, Region I). This region is highly flexible and is disordered in the crystal structure of HiDapET (no electron density observed for residues 182187). Region II (residues 209224), which corresponds to a loop overhanging the active site metal ions (loop V, vide infra) adopts a different conformation in comparison to that observed in the HiDapE structure (rmsd of 1.5 A between the structures). Two residues within loop V (Gly21 and Gly212) are disordered in the structure of HiDapET (Figure 1C). Structure of the catalytic domain of VcDapET The monomeric state of VcDapET was confirmed by SEC (the estimated MW of 28.7 kDa) and DLS measurements (the estimated average MW of 23.2 kDa) (Table 2). Two VcDapET structures were determined, the apo- and the dinuclear Zn(II)loaded form. The final models for both apo- and Zn(II)-loaded VcDapET included two molecules of the catalytic domain in the asymmetric unit. The two V. cholerae structures are virtually identical and superimpose with the average rmsd of 0.25 A for 265 equivalent Ca atoms suggesting that binding of Zn(II) does not induce any major structural changes (Figure 2A). The structures of the catalytic domains of both apo- and Zn(II)-loaded VcDapET closely resemble that of the catalytic domain of active WTHiDapE (PDB ID 3IC1). Superimposition of the Zn(II)-loaded VcDapET structure and Zn(II)-loaded HiDapET shows that they also overlay closely with (the average rmsd of 0.81 A for 248 equivalent Ca atoms, Z-score 17, sequence similarity 59%) (Figure 2B). Likewise, the structure of Zn(II)-loaded VcDapET is almost identical to that of the catalytic domain of the full-length HiDapE with rmsd of 1.15 A. The similarity between these structures is especially apparent within the active site region of Zn(II)-loaded VcDapET as the active site structure differs by only ,0.45 A rmsd with the active site of HiDapET and ,0.4 A with the WT-HiDapE (Figure 2A and B). Similarly to HiDapET, the most flexible regions of the protein are Region I and Region II. Region I corresponds to the engineered loop (the connector) where the deleted dimerization domain is replaced with two glycines. Region II (residues 210224) forms a loop overhanging the active site metal ions, which includes residues 211213 that form part of loop V (vide infra) (Figure 2B). The active sites of HiDapET and VcDapET The sequence identity of HiDapE and VcDapE is high (59%), and the residues comprising the active site are fully conserved. The active site of DapE is located in the center of the catalytic domain above the centrally located parallel strands of the b-sheet and is formed by six loops [loop I (H. influenzae notation, residues 6875), loop II (residues 95102), loop III (residues 132141), loop IV (residues 162174), loop V (residues 322328 in HiDapE) and loop VI (residues 341355)] (Figure 1B). With the exception of loop V that does not interact with the zinc ions, the remaining loops contribute the conserved residues that coordinate the metal ions (Figures 1B, 1C & 2B). Interestingly, loops IIV and VI are in virtually identical orientations in both VcDapET and HiDapET and overlay very well with the corresponding loops in WTHiDapE. A change is observed in loop V, which in VcDapET adopts a conformation that is significantly different from the one observed for WT-HiDapE (Figures 1A & 2B) (in HiDapET this loop is disordered). The active site of Zn(II)-loaded VcDapET contains a (m-oxygen)(m-carboxylato)dizinc(II) core with one terminal carboxylate and one histidine residue at each metal site ([ZnZn(VcDapET)]), that is identical to the active site observed for WT-HiDapE [16]. The main difference between the active sites in the two Zn(II)-loaded H. influenzae structures (WT-HiDapE and HiDapET) and [ZnZn(VcDapET)] is the presence of additional electron density in chain A, which is overlapping with the bridging water/hydroxide molecule observed in chain B and WT-HiDapE. The 2Fo-Fc and Fo-Fc electron density maps were quite clear and indicate that a small molecule (most likely ethylene glycol or a partially disordered glycerol molecule) (Figure 2C) displaces the bridging water/hydroxide molecule in the [ZnZn(HiDapE)] and [ZnZn(HiDapET)] structures. Both of these compounds were present in the cryoprotectant solution. Based on the best fit, an ethylene glycol molecule was modeled in the active site resulting in a distorted tetrahedral coordination geometry for Zn1, which is bound by the carboxylate oxygen atoms OD1 of D101 and OE1 of E164 as well as a nitrogen atom NE2 of H68. Zn2 adopts a distorted trigonal bipyramidal geometry and is coordinated by the bridging O2 oxygen atom from ethylene glycol, a nitrogen atom NE2 of H239, two oxygen atoms, OD2 from D101 and OE2 from E136, and the O1 oxygen atom of ethylene glycol (Figure 2D). The Zn1-Zn2 distance is 3.39 A. Molecular Modeling and Dynamics MD calculations were performed for five proteins: VcDapET, HiDapET, WT-VcDapE, WT-HiDapE and AAP. After equilibration, the rmsd values for the main-chain atoms of [ZnZn(VcDa yeop saePd .rcu a i id rep ehn isaon iltsed .lenop pET)] and [ZnZn(HiDapET)] were compared with the original Xray structures and only small changes were observed. Similarly, small changes were seen after equilibration of VcDapE and HiDapE as well as AAP, which is monomeric and contains a single catalytic domain. Since only the two truncated proteins were catalytically inactive, particular attention was given to how these proteins differed from the other three. Figure 3 shows the results of the 5 ns molecular dynamics simulations of the truncated proteins and comparisons to their crystallographic temperature factors. All of the MOLMOL plots used only the first 5 ns of data so that they are directly comparable. The thickness of the line indicates the flexibility of the structure at a given point during the simulation (Figure 3A and B). The portions of [ZnZn(VcDapET)] that have the greatest flexibility include the created dimerization domain loop and the active site loop V (Figure 2). This is consistent with the crystallographic atomic displacement parameters indicating that the most dynamic portions includes residues 177187 and loop V (Figure 3C). Compared to the other three structures, the two truncated proteins have greater flexibility in both of these loops (Figure 3) than the wild-type proteins (Figure 4). Mutation of the Loop V Residue T325 Since both X-ray crystallographic and MD simulations suggested that loop V flexibility increases in VcDapET and HiDapET, it was hypothesized that this loop plays an important role in constituting the active site and possibly substrate recognition and/or transition-state stabilization. Since T325 in HiDapE is centrally positioned in loop V directly above the dinuclear Zn(II) site (Figure 5), the site-directed mutants T325A, T325S and T325C were prepared and purified. The kcat value obtained for T325A using L,L-SDAP as the substrate was 460.5 s21 with a corresponding Km value of 2.160.2 mM while the kcat value obtained for T325S was 2.960.3 s21 with a Km value of 3.060.3 mM. Interestingly, when T325 was replaced by cysteine, no enzyme activity was observed under standard assay conditions. CD spectra obtained for each mutant enzyme plus WT-HiDapE, indicate no significant structural change in the mutant enzymes. These data confirm that T325 and hence the position of loop V is important for the active site organization and catalysis. Discussion Sequence comparison of all M20 classified metallopeptidases and the M28 family of dinuclear Zn(II)-dependent metalloproteases, which include AAP and CPG2 [17,18,35], shows that all of the metal coordinating residues are strictly conserved [10,23,36,37]. Unlike AAP, which is monomeric, DapE enzymes form dimers where each subunit consists of two functional domains: a larger catalytic domain, which houses the active site and a dimerization domain that forms the dimer interface (Figure 1A). The location and architecture of the catalytic domain and the dinuclear Zn(II) active site in dimeric WT-HiDapE is nearly identical to the catalytic domain and the active site of monomeric AAP [17,38]. The catalytic domain of HiDapE is composed of residues 1179 and 293376 where the core of the catalytic domain contains an eight-stranded twisted b-sheet that is sandwiched between seven a-helices. The active site is located in the center of the catalytic domain above the centrally located parallel strands of the b-sheet and is constituted by six loops. With the exception of loop V that encloses the active site from the top and does not interact with the zinc ions, the remaining loops contribute the conserved residues that coordinate the metal ions (Figure 1B). The dimerization domain of HiDapE consists of a 114-residue insertion into the catalytic domain and is connected to the catalytic domain by two short loops. Since the dimerization domain is located away from the active site and has only limited interaction with the catalytic domain via loop V, it is unclear whether this domain plays any role in catalysis. Such a role for the dimerization domain would require a major conformational change to bring the dimerization domain residues into the active site. While this is possible, the time frame would be well beyond the range of atomistic MD simulations. To address this issue, we engineered DapE enzymes with no dimerization domains (HiDapET, VcDapET). The nested truncation was designed based on the WT-HiDapE crystal structures with the goal of preserving the catalytic domain structure and keep its active site intact. The HiDapET and VcDapET constructs expressed well, were purified, the monomeric states of both proteins in solution was confirmed, and their catalytic activities examined. Surprisingly, we could not detect enzyme activity for either truncated variant towards L,L-SDAP, whereas WTHiDapE exhibited kcat and Km values in good agreement with those previously reported [23]. For comparison purposes, the kcat and Km were also determined for WT-VcDapE and found to be similar to the values reported for WT-HiDapE. These data suggest that the deletion mutants have significantly diminished catalytic activity or are fully catalytically inactive. To understand the structural basis of the observed absence of catalytic activity of both engineered enzymes, we determined the crystal structures of the truncated forms of HiDapET ([ZnZn(HiDapET)]) and VcDapET ([ZnZn(VcDapET)]) along with the apoform of VcDapET. These structures reveal that the catalytic domain is indeed unchanged, including complete structural preservation of the catalytic site and metal core. It is clear that deletion of the dimerization domain does not compromise the catalytic domain structure. The structure of [ZnZn(HiDapET)] is virtually identical to the catalytic domain the WT-HiDapE with an rmsd of 0.8 A for 248 equivalent Ca atoms. Interestingly, the newly determined structure of [ZnZn(VcDapET)] also shows high similarity to the catalytic domain of WT-HiDapE with an rmsd of 1.15 A for 246 equivalent Ca atoms. Since the structures of VcDapET were determined in both the apo- and dinuclear Zn(II)loaded forms, it is evident that removal of either the dimerization domain or the metal cations does not alter the overall structure of the catalytic domain. The dinuclear Zn(II) active sites in both HiDapET and VcDapET are nearly identical to each other with Zn-Zn distances of ,3.40 A. These Zn-Zn distances are comparable to those observed for AAP (3.45 A), HiDapE (3.33 A) and carboxypeptidase G2 (CPG2) (3.25 A) [18,37]. Similar to AAP, HiDapE, and CPG2 one of the Zn(II) ions in [ZnZn(VcDapET)] adopts a distorted tetrahedral geometry while the second Zn(II) ion is trigonal bipyramidal. Identical to CPG2, HiDapE, and AAP each zinc ion is coordinated by one imidazole group (H68 for Zn1 and H239 for Zn2) and the oxygen atoms of E164 for Zn1 and E136 for Zn2. Both zinc ions are bridged by D101 and a single oxygen atom of ethylene glycol (in the molecule one, chain A) and a water molecule (in the second molecule, chain B). Overall the [ZnZn(VcDapET)] structure confirms that the metal ions form a (m-oxygen)(m-carboxylato)dizinc(II) core similar to HiDapE, AAP, and CPG2 [39], and indicates that the active site catalytic unit is intact in the truncated forms of DapE. Therefore, the lack of the catalytic activity is puzzling and clearly is not due to missing a key element in the HiDapET and VcDapET dinuclear active site. Comparison of the [ZnZn(HiDapET)] and [ZnZn(VcDapET)] structures with that of WT-HiDapE (PDB ID 3IC1) (Figure 1C & 2B) reveals that one of the six loops comprising the catalytic core, loop V (residues 210214 in HiDapET and 211215 in VcDapET, and corresponding to 321325 in HiDapE) exists in a significantly different orientation than that observed in WT-HiDapE. Interestingly, this loop is also partially disordered in the structure of HiDapET, while in VcDapET structures its conformational flexibility is signified by the double conformation of the main chain Gly 213 (peptide flip). In previous studies, we proposed that this loop might be involved in the positioning and stabilization of the substrate in the active site, therefore the loop conformation might be critical for proper substrate binding and positioning as well as stabilization of the transition-state during the catalytic cycle [16]. This is supported by two loop V mutations (T325A, T325S) that show similar Km to WT but significantly reduced (2550 times) kcat values. These data suggest that the substrate is bound with similar specificity, but is not effectively presented to the catalytic core for successful catalysis. Since the same region is affected in both HiDapET and VcDapET, where loop V is out of place compared to the WT-HiDapE, we hypothesized that this region is important for catalysis. Both of the observed orientations and the greater flexibility of this loop (Figures 2B & 3) seem to be due to the lack of interactions with specific portions of the dimerization domain. Several interactions may be particularly critical. First, loop V in WT-HiDapE is partially held in position by the anti-parallel beta strands (b7 and b12) and interactions with a loop connecting b7 with the dimerization domain. These contacts are missing in the truncated protein as portions of strands b7 and b12 have been transformed into a deletion-derived loop and a helix (Figure 2B). Loop V in WT-HiDapE is also held in place by the loop from the dimerization domain (residues 223 to 228) (Figure 6). These contacts are also missing in the truncated protein. Interestingly, the structure of WT-HiDapE contains a sulfate ion located at the interface of the catalytic and dimerization domains and positioned very closely to loop V. The sulfate binding may have biological relevance and might indicate a region where the L,L-diaminopimelic acid moiety of the substrates binds. Several residues from both domains interact with this sulfate ion. These include Arg178 (NE), Arg179 (NH), and Gly324 (amide NH; residue in loop V) from the catalytic domain and Arg258 (NH) from the dimerization domain (corresponding to Arg179, Arg180, Figure 3. Diagrams Showing Regions of Flexibility in Truncated DapE Proteins. A) MOLMOL diagram of [ZnZn(VcDapET)] molecular dynamics. B) MOLMOL diagram of [ZnZn(HiDapET)] molecular dynamics (the thickness of the line is proportional to the variation of the protein structure during the simulation). The crystallographic temperature factors indicating that the most dynamic (in red) and the most rigid (in blue) parts of the protein: C) [ZnZn(VcDapET)]. D) [ZnZn(HiDapET)]. doi:10.1371/journal.pone.0093593.g003 Gly325 and Arg259 in WT-VcDapE) (Figure 6). This interaction is completely absent in the structure of the [ZnZn(VcDapET)] and residues Arg178 and Arg179 are part of the deletion-derived distorted a helix, whereas Gly214 (corresponding to Gly324 in WT-HiDapE) located within loop V does not form any observable interactions (Figure 6). Another indication that the specific orientation of loop V may be crucial for catalysis comes from MD simulations of the truncated DapE structures compared to WT-DapE and AAP (Figure 4). Consistent with the large crystallographic temperature factors, the greatest flexibility in the truncated forms of DapE are observed in the engineered loop created to replace the deleted dimerization domain and loop V, which directly overhangs the dinuclear active site (Figure 3C and D). For comparison, loop V in the apo-structure of NmDapE (PDB entry 1vgy) is well ordered and positioned such that it allows two arginine residues (Arg179, Arg259 corresponding to the pairs Arg178/Arg258 and Arg179/ Arg259 in HiDapE and VcDapE, respectively) to closely approach the active site. It is highly likely that these Arg residues, which are semi-conserved (Arg178) or conserved (Arg259) in DapEs, might interact with the carboxylate moieties of the substrate. Conserved Arg residues were shown to be essential for substrate binding in human aminoacylase-1 (Acy1) (40). Interestingly in AAP, which exists as a monomeric protein of only the single catalytic domain, there is a loop residing directly over the dinuclear zinc active site that corresponds to loop V in DapE. This loop is very rigid, unlike loop V in DapE, and appears to be held in place by an internal disulfide bridge formed between C223 and C227 (Figure 6). A decrease in dynamic flexibility due to changes in quaternary structure has been suggested for other proteins [40]. Apart from loop V, an additional loop might play an important role in catalysis. Studies on Acy1, another dimeric member of the Figure 4. Molecular Dynamic Simulation Showing Regions of Flexibility in Catalytic Domain. A) [ZnZn(VcDapE)]. B) [ZnZn(HiDapE)]. C) AAP. The thickness of the line is proportional to the variation of the protein structure during the simulation. AS indicates the active site area, LVeq. equivalent of the LV loop in HiDapE). doi:10.1371/journal.pone.0093593.g004 M20 family, showed that the dimerization domain contributes to the active site through interactions with the substrate (40). Lindner et al. (40) showed that the alanine mutant of His206, which is located at the center of the loop, rendered the enzyme nearly inactive. An equivalent histidine residue is conserved in DapE enzymes (H194 in HiDapE and H195 in VcDapE), but it is disordered in the WT-HiDapE structure (17). Modeling of this disordered loop region (Figure 1A) positions H194 roughly ,13 A from the active site core, which is likely too far to interact with the substrate. However, it is possible that this loop can rearrange upon substrate binding as was reported for Acy1 and Sapep [40,41]. Evidence for such loop movement can be gleaned from the structure of apo-NmDapE where this loop is positioned within 8 A of the active site. These data suggest that this His residue may also play an important role in substrate recognition and binding by DapE enzymes. This hypothesis is consistent with the wild-type DapE structural design as the presence of the inter-domain clefts and connectors would allow for significant movement of this domain. Confirmation of the role of His194 in substrate recognition and binding must await a structure of DapE in complex with a substrate analog. Removal of the dimerization domain in DapE enzymes renders the enzyme inactive, even though the resulting truncated proteins have structures of the catalytic domain that are remarkably similar to WT-DapE and AAP. In fact, the dinculear Zn(II) site in the truncated DapE enzymes is nearly identical to those observed for AAP and WT-HiDapE. Therefore, one would expect that the active site should be capable of catalyzing a hydrolytic reaction and yet no activity is detected. This suggests that positioning of the substrate in the active site is critical for the catalytic reaction to occur. Analysis of the structures HiDapET and VcDapET reveals that loop V is much more flexible in the truncated enzymes than WT-DapE due to the lack of interactions provided by the dimerization domain. These data suggest that the dimerization domain functions to restrict the conformational freedom of the loop V region and may contribute residues to the active site environment (H194, R179, R258, T325) that are important for substrate recognition, and binding. Designing small molecules inhibitors that interact with this active site loop V region as well as the dinuclear metal center, or disrupting dimer formation may lead to more potent DapE inhibitors that can function as antibacterial agents. Supporting Information File S1 A. Analysis of the oligomeric state by size exclusion chromatograpy. Chromatogram showing elution of three DapE proteins (WT-HiDapE (blue), HiDapET (red), VcDapET(green)) from the calibrated column. The inset shows the calibration curve obtained by plotting Kav versus logMW forthe following standard proteins: Aprotinin (6.5 kDa, I), ribonuclease A (13.7 kDa, II), carbonic anhydrase (29 kDa, III) ovalbumin (43 kDa, IV), conalbumin (75 kDa,V), aldolase (158 kDa, VI), ferritin (440 kDa, VII), and thyroglobulin (669 kDa, VIII). B. The secondary structure of WT DapE and T325 mutants were measured using OlisDSM 20 circular dichrometer. Data was collected at room temperature with constant nitrogenflow every 1 nm, in the wavelength range of 190260 nm. All samples were measured in acylindrical quartz cuvette with a 1 mm pathlength in 10 mM phosphate buffer pH 7.0. Threerepetitive scans were averaged, smoothed and background-subtracted for each measurement. Millidegree values obtained were converted to molar ellipticity (deg?cm2?dmol-1) by using the equation: Molar ellipticity = moM/106L6C, where mo is millidegrees, M is molecular weight (g/mol), L is path length of cuvette (cm) and C is concentration (g/L). (DOCX) Conceived and designed the experiments: BN RCH. Performed the experiments: AS MMG BG SS RJ JCM. Analyzed the data: BN KWO AJ RCH. Wrote the paper: BN RCH. 1. Levy SB ( 1998 ) The Challenge of Antibiotic Resistance . Sci Am 278 : 46 - 53 . 2. Nemecek S ( 1997 ) Beating Bacteria. New ways to Fend off Antibiotic-Resistant Pathogens . Sci Am 276 : 38 - 39 . 3. Spellberg B , Powers JH , Brass EP , Miller LG , Edwards JE Jr ( 2004 ) Trends in antimicrobial drug development: implications for the future . Clin Infect Dis 38 : 1279 - 1286 . 4. Howe RA , Bowker KE , Walsh TR , Feest TG , MacGowan AP ( 1998 ) Vancomycin-Resistant Staphylococcus aureus . Lancet 351 : 601 - 602 . 5. Teuber M ( 1999 ) Spread of Antibiotic Resistance with Food-Borne Pathogens . Cell Mol Life Sci 56 : 755 - 763 . 6. Miller JR , Dunham S , Mochalkin I , Banotai C , Bowman M , et al. ( 2009 ) A Class of Selective Antibacterials Derived from a Protein Kinase Inhibitor Pharmacophore . Proc Natl Acad Sci U S A 106 : 1737 - 1742 . 7. Girodeau J-M , Agouridas C , Masson M , LeGoffic F ( 1986 ) The Lysine Pathway as a Target for a New Genera of Synthetic Antibacterial Antibiotics? J Med Chem 29 : 1023 - 1030 . 8. Hutton CA , Peruginibc MA , Gerrard JA ( 2007 ) Inhibition of Lysine Biosynthesis: An Evolving Antibiotic Strategy . Mol BioSyst 3 : 458 - 465 . 9. Scapin G , Blanchard JS ( 1998 ) Enzymology of Bacterial Lysine Biosyntesis . Adv Enzymol 72 : 279 - 325 . 10. Born TL , Zheng R , Blanchard JS ( 1998 ) Hydrolysis of N-succinyl-L,-LDiaminopimelic Acid by the Haemophilus influenzae dapE-Encoded Desuccinylase: Metal Activation , Solvent Isotope Effects, and Kinetic Mechanism . Biochemistry 37 : 10478 - 10487 . 11. Born TL , Blanchard JS ( 1999 ) Structure/Function Studies on Enzymes in the Diaminopimelate Pathway of Bacterial Cell Wall Synthesis . Cur Opin Chem Biol 3 : 607 - 613 . 12. Karita M , Etterbeek ML , Forsyth MH , Tummuru MR , Blaser MJ ( 1997 ) Characterization of Helicobacter pylori DapE and Construction of a Conditionally Lethal DapE Mutant . Infect Immun 65 : 4158 - 4164 . 13. Pavelka MS , Jacobs WR ( 1996 ) Biosynthesis of Diaminopimelate, the Precursor of Lysine and a Component of Peptidoglycan, is an Essential Function of Mycobacterium smegmatis . J Bacteriol 178 : 6496 - 6507 . 14. Gillner D , Becker D , Holz R ( 2013 ) Lysine biosynthesis in bacteria: a metallodesuccinylase as a potential antimicrobial target . JBIC Journal of Biological Inorganic Chemistry 18 : 155 - 163 . 15. Gillner DM , Bienvenue DL , Nocek BP , Joachimiak A , Zachary V , et al. ( 2009 ) The dapE-Encoded N-Succinyl-L,L-Diaminopimelic Acid Desuccinylase from Haemophilus influenzae Contains two Active Site Histidine Residues . J Biol Inorg Chem 14 : 1 - 10 . 16. Nocek BP , Gillner DM , Fan Y , Holz RC , Joachimiak A ( 2010 ) Structural Basis for Catalysis by the Mono- and Dimetalated Forms of the dapE- Encoded Nsuccinyl-L,L-Diaminopimelic Acid Desuccinylase. J Mol Biol 397 : 617 - 626 . 17. Rowsell S , Pauptit RA , Tucker AD , Melton RG , Blow DM , et al. ( 1997 ) Crystal Structure of Carboxypeptidase G2, a Bacterial Enzyme with Applications in Cancer Therapy . Structure 5: 337 - 347 . 18. Desmarais W , Bienvenue DL , Bzymek KP , Petsko GA , Ringe D , et al. ( 2006 ) The High-Resolution Structures of the Neutral and the Low pH Crystals of the Aminopeptidase from Aeromonas proteolytica . J Biol Inorg Chem 11 : 398 - 408 . 19. Kim Y , Babnigg G , Jedrzejczak R , Eschenfeldt WH , Li H , et al. ( 2011 ) Highthroughput protein purification and quality assessment for crystallization . Methods 55 : 12 - 28 . 20. Nocek B , Stein AJ , Jedrzejczak R , Cuff ME , Li H , et al. ( 2011 ) Structural Studies of ROK Fructokinase YdhR from Bacillus subtilis: Insights into Substrate Binding and Fructose Specificity . Journal of Molecular Biology 406 : 325 - 342 . 21. Bergmann M , Stein WH ( 1939 ) Naphthalene-b-sulfonic acid as a reagent for amino acids . J Biol Chem 129 : 609 - 618 . 22. Lin Y , Myhrman R , Schrag ML , Gelb MH ( 1988 ) Bacterial N-succinyl-LDiaminopimelic Acid Desuccinylase . Purification, Partial Characterization , and Substrate Specificity . J Biol Chem 263 : 1622 - 1627 . 23. Bienvenue DL , Gilner DM , Davis RS , Bennett B , Holz RC ( 2003 ) Substrate Specificity, Metal Binding Properties, and Spectroscopic Characterization of the dapE-Encoded-N-succinyl-L,L-Diaminopimelic Acid Desuccinylase from Haemophilus influenzae . Biochemistry 42 : 10756 - 10763 . 24. Adams PD , Afonine PV , Bunkoczi PV , Chen VB , Davis IW , et al. ( 2010 ) PHENIX: a comprehensive Python-based system for macromolecular structure solution . Acta Cryst D66 : 213 - 221 . 25. Vagin A , Teplyakov A ( 2000 ) An approach to multi-copy search in molecular replacement . Acta Crystallogr D Biol Crystallogr 56 : 1622 - 1624 . 26. ( 1994 ) The CCP4 suite: programs for protein crystallography . Acta Crystallogr D Biol Crystallogr 50 : 760 - 763 . 27. Murshudov GN , Vagin AA , Dodson EJ ( 1997 ) Refinement of macromolecular structures by the maximum-likelihood method . Acta Crystallogr D Biol Crystallogr 53 : 240 - 255 . 28. Humphrey W , Dalke A , Schulten K ( 1996 ) VMD: Visual molecular dynamics . J Mol Graphics 14 : 33 . 29. Jorgensen WL , Chandrasekhar J , Madura JD , Impey RW , Klein ML ( 1983 ) Comparison of simple potential functions for simulating liquid water . J Chem Phys 79 : 926 - 935 . 30. MacKerell AD Jr, Banavali N , Foloppe N ( 2001 ) Development and current status of the CHARMM force field for nucleic acids . Biopolymers 56 257 - 265 . 31. Phillips JC , Braun R , Wang W , Gumbart J , Tajkhorshid E , et al. ( 2005 ) Scalable molecular dynamics with NAMD . J Comp Chem 26 : 1781 - 1802 . 32. Guex N , Peitsch MC ( 1997 ) SWISS-MODELand the Swiss-PdbViewer: An environment for comparative protein modeling . Electrophoresis 18 : 2714 - 2723 . 33. Arnold K , Bordoli L , Kopp J , Schwede T ( 2006 ) The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling . Bioinformatics 22 : 195 - 201 . 34. Koradi R , Billeter M , Wuthrich K ( 1996 ) MOLMOL: A program for display and analysis of macromolecular structures . J Mol Graphics 14 : 51 - 55 . 35. Barrett AJ , Rawlings ND , Woessner JF, editors( 1998 ) Handbook of Proteolytic Enzymes . London: Academic Press. 1 - 1666 p. 36. Chevrier B , Schalk C , D'Orchymont H , Rondeau J-M , Moras D , et al. ( 1994 ) Crystal Structure of Aeromonas proteolytica Aminopeptidase: A Prototypical Member of the Co-Catalytic Zinc Enzyme Family . Structure 2: 283 - 291 . 37. Greenblatt HM , Almog O , Maras B , Spungin-Bialik A , Barra D , et al. ( 1997 ) Streptomyces griseus Aminopeptidase: X-ray Crystallographic Structure at 1.75 A Resolution . J Mol Biol 265 : 620 - 636 . 38. Chevrier B , D'Orchymont H , Schalk C , Tarnus C , Moras D ( 1996 ) The structure of the Aeromonas proteolytica aminopeptidase complexed with a hydroxamate inhibitor . Involvement in catalysis of Glu151 and two zinc ions of the cocatalytic unit . Eur J Biochem 237 : 393 - 398 . 39. Cosper NJ , Bienvenue DL , Shokes JE , Gilner DM , Tsukamoto T , et al. ( 2003 ) The dapE-Encoded N-succinyl-L,L-Diaminopimelic Acid Desuccinylase from Haemophilus influenzae is a Dinuclear Metallohydrolase . J Am Chem Soc 125 : 14654 - 14655 . 40. Griffin MDW , Dobson RCJ , Pearce FG , Antonio L , Whitten AE , et al. ( 2008 ) Evolution of Quaternary Structure in a Homotetrameric Enzyme . J Mol Biol 380 : 691 - 703 . 41. Girish TS , Gopal B ( 2010 ) J Biol Chem 285 : 29406 - 29415 .


This is a preview of a remote PDF: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093593&type=printable

Boguslaw Nocek, Anna Starus, Magdalena Makowska-Grzyska, Blanca Gutierrez, Stephen Sanchez, Robert Jedrzejczak, Jamey C. Mack, Kenneth W. Olsen, Andrzej Joachimiak, Richard C. Holz. The Dimerization Domain in DapE Enzymes Is required for Catalysis, PLOS ONE, 2014, DOI: 10.1371/journal.pone.0093593